OR2H2 and atherosclerosis: Genetic deletion of OLFR2, receptor transporter proteins 1 and 2, and downstream adenylate cyclase 3 in the bone marrow ameliorated atherosclerosis, as evidenced by a reduction in plaque vulnerability and an increase in collagen content, which are related to plaque stability.